Industry

DUBLIN–(BUSINESS WIRE)–The “Global Big Pharma Partnering Terms and Agreements 2015-2022” report has been added to ResearchAndMarkets.com’s offering. The Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to … [Read more…]

Investment in purpose-built facilities supports ongoing recruitment and growth in new product development activities First phase of new facility doubles overall space capacity, with view to expand further as later stages of building complete CAMBRIDGE, England–(BUSINESS WIRE)–Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it … [Read more…]

Drug discovery leader Dr James Osborne brings strong track record of delivering drug candidates for oncology and CNS disorders Proteros selected for its cutting-edge structure-based drug discovery engine Signals new phase as Adrestia moves a portfolio of validated synthetic rescue targets into drug discovery for genetically defined neurologic and cardiomyopathic diseases CAMBRIDGE, England–(BUSINESS WIRE)–Adrestia Therapeutics, … [Read more…]

Supported by TELUS Health, LifeWorks’ Mental Health Index™ finds erosion of employer trust leads to worsened mental health among employees TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions supported by TELUS Health, today released its monthly Mental Health Index™ revealing that one out of five (20 per cent) Canadians believe trust … [Read more…]

Supported by TELUS Health, LifeWorks Mental Health Index™ finds that workers who perceive a decline in trust between employees and employers score seven points lower on the Mental Health Index™ than the national average CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total well-being solutions supported by TELUS Health, today released its monthly Mental … [Read more…]

Dr Enrica Alteri has extensive experience in drug discovery and clinical safety and worked at the European Medicines Agency for 8 years, serving on its Executive Board Prof Jeffrey Skopek is Associate Professor of Law at the University of Cambridge and Deputy Director of its Centre for Law, Medicine and Life Sciences. CAMBRIDGE, England–(BUSINESS WIRE)–#Celltherapy–Today … [Read more…]

Results demonstrate statistically significant efficacy of drug candidate nangibotide in the treatment of patients with severe forms of COVID-19 Nangibotide treatment improves patients’ clinical status and shows a relative 43% reduction in mortality The company will consult with regulatory authorities to advance a new treatment option to severe COVID-19 patients ESSENTIAL was made possible thanks … [Read more…]

At the Tuesday, October 25th Board of Water and Power Commissioners’ meeting, Activists will give public comment to stop DWP from acting as a barrier to the building of new affordable housing Activists will demand that the DWP provide power to buildings that will service 100% affordable housing much faster and for less money LOS … [Read more…]

− Oral presentation highlighted at American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting – MONROE TOWNSHIP, N.J. & OXFORD, England–(BUSINESS WIRE)–Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced results from its Phase 3 SPOTLIGHT trial that evaluated the impact of various clinical … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer–MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that on October 21, 2022 it finalized Closing of the private placement of Series III Convertible Loan Notes (“Series III Notes”) which, since it was first announced, has comprised issuance of a total of … [Read more…]